Caribou Biosciences (CRBU) Net Cash Flow (2020 - 2025)
Historic Net Cash Flow for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to -$14.1 million.
- Caribou Biosciences' Net Cash Flow fell 13867.03% to -$14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.9 million, marking a year-over-year increase of 7106.59%. This contributed to the annual value of -$34.9 million for FY2024, which is 38591.14% down from last year.
- According to the latest figures from Q3 2025, Caribou Biosciences' Net Cash Flow is -$14.1 million, which was down 13867.03% from -$4.2 million recorded in Q2 2025.
- Caribou Biosciences' Net Cash Flow's 5-year high stood at $305.8 million during Q3 2021, with a 5-year trough of -$194.9 million in Q4 2021.
- In the last 5 years, Caribou Biosciences' Net Cash Flow had a median value of -$11.5 million in 2024 and averaged -$252368.4.
- Data for Caribou Biosciences' Net Cash Flow shows a peak YoY increase of 366269.37% (in 2021) and a maximum YoY decrease of 216774.49% (in 2021) over the last 5 years.
- Quarter analysis of 5 years shows Caribou Biosciences' Net Cash Flow stood at -$194.9 million in 2021, then soared by 87.82% to -$23.7 million in 2022, then tumbled by 122.75% to -$52.9 million in 2023, then skyrocketed by 70.36% to -$15.7 million in 2024, then rose by 10.24% to -$14.1 million in 2025.
- Its Net Cash Flow stands at -$14.1 million for Q3 2025, versus -$4.2 million for Q2 2025 and $13.1 million for Q1 2025.